Introduction: Defects of prokineticin pathway affect the neuroendocrine control of reproduction, but their role in the pathogenesis of central hypogonadism remains undefined, and the functional impact of the missense PROKR2 variants has been incompletely characterized. Material and Methods: In a series of 246 idiopathic central hypogonadism patients,wefound three novel (p.V158I, p.V334M, and p.N15TfsX30) and six already known (p.L173R, p.T260M, p.R268C, p.V274D, p.V331M, and p.H20MfsX23) germline variants in the PROKR2 gene. We evaluated the effects of seven missense alterationsontwodifferent prokineticin receptor 2 (PROKR2)-dependent pathways: inositol phosphate-Ca2+ (Gq coupling) and cAMP (Gs coupling). Results: PROKR2 variants were found in 16 patients (6.5%). Expression levels of variants p.V158I and p.V331M were moderately reduced, whereas they were markedly impaired in the remaining cases, except p.V334M, which was significantly overexpressed. The variants p.T260M, p.R268C, and p.V331M showed no remarkable changes in cAMP response (EC50) whereas the IP signaling appeared more profoundly affected. In contrast, cAMP accumulation cannot be stimulated through the p.L173R and p.V274D, but IP EC50 was similar to wt inp.L173R and increased by 10-fold in p.V274D. The variant p.V334M led to a 3-fold increase of EC50 for both cAMP and IP. Conclusion: Our study shows that single PROKR2 missense allelic variants can either affect both signaling pathways differently or selectively. Thus, the integrity of both PROKR2-dependent cAMP and IP signals should be evaluated for a complete functional testing of novel identified allelic variants.

Germline prokineticin receptor 2 (PROKR2) variants associated with central hypogonadism cause differental modulation of distinct intracellular pathways / D.V. Libri, G. Kleinau, V. Vezzoli, M. Busnelli, F. Guizzardi, A.A. Sinisi, A.I. Pincelli, A. Mancini, G. Russo, P. Beck-Peccoz, S. Loche, C. Crivellaro, M. Maghnie, C. Krausz, L. Persani, M. Bonomi. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - 99:3(2014 Mar), pp. E458-E463.

Germline prokineticin receptor 2 (PROKR2) variants associated with central hypogonadism cause differental modulation of distinct intracellular pathways

D.V. Libri
Primo
;
V. Vezzoli;M. Busnelli;F. Guizzardi;P. Beck-Peccoz;L. Persani
;
M. Bonomi
Ultimo
2014-03

Abstract

Introduction: Defects of prokineticin pathway affect the neuroendocrine control of reproduction, but their role in the pathogenesis of central hypogonadism remains undefined, and the functional impact of the missense PROKR2 variants has been incompletely characterized. Material and Methods: In a series of 246 idiopathic central hypogonadism patients,wefound three novel (p.V158I, p.V334M, and p.N15TfsX30) and six already known (p.L173R, p.T260M, p.R268C, p.V274D, p.V331M, and p.H20MfsX23) germline variants in the PROKR2 gene. We evaluated the effects of seven missense alterationsontwodifferent prokineticin receptor 2 (PROKR2)-dependent pathways: inositol phosphate-Ca2+ (Gq coupling) and cAMP (Gs coupling). Results: PROKR2 variants were found in 16 patients (6.5%). Expression levels of variants p.V158I and p.V331M were moderately reduced, whereas they were markedly impaired in the remaining cases, except p.V334M, which was significantly overexpressed. The variants p.T260M, p.R268C, and p.V331M showed no remarkable changes in cAMP response (EC50) whereas the IP signaling appeared more profoundly affected. In contrast, cAMP accumulation cannot be stimulated through the p.L173R and p.V274D, but IP EC50 was similar to wt inp.L173R and increased by 10-fold in p.V274D. The variant p.V334M led to a 3-fold increase of EC50 for both cAMP and IP. Conclusion: Our study shows that single PROKR2 missense allelic variants can either affect both signaling pathways differently or selectively. Thus, the integrity of both PROKR2-dependent cAMP and IP signals should be evaluated for a complete functional testing of novel identified allelic variants.
septo-optic dysplasia; hormone defiency; Kallmann-syndrome; olfactory-bulb; genetic-basis; hypopituitarism; mutations
Settore MED/13 - Endocrinologia
Idiopathic Central Hypogonadism (ICH) as an emerging clinical problem: Investigations on the disrupted signals underlying its pathogenesis and generation of an efficient national network for its diagnosis and management
25-nov-2013
Article (author)
File in questo prodotto:
File Dimensione Formato  
prokr2 mut, JCEM 2014.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 787.53 kB
Formato Adobe PDF
787.53 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/270740
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 17
social impact